Identification of a genetic locus responsible for antimicrobial peptide resistance in clostridium difficile

Infection and Immunity

Volumn 79, Issue 1, 2011, Pages 167-176

  McBride, Shonna M ^a   Sonenshein, Abraham L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATIONIC ANTIMICROBIAL PEPTIDE; GALLIDERMIN; MAGAININ 2; NISIN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN HISTIDINE KINASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM MUTANT; CD1352 GENE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; GENETIC TRANSCRIPTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION; WILD TYPE;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; CLOSTRIDIUM DIFFICILE; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; NISIN;

EID: 78650902755     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00731-10     Document Type: Article

References (73)

1. Ananthakrishnan, A. N., E. L. McGinley, and D. G. Binion. 2008. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57:205-210.
2. Aso, Y., K. Okuda, J. Nagao, Y. Kanemasa, N. Thi Bich Phuong, H. Koga, K. Shioya, T. Sashihara, J. Nakayama, and K. Sonomoto. 2005. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci. Biotechnol. Biochem. 69:1403-1410.
3. Barbut, F., D. Decre, V. Lalande, B. Burghoffer, L. Noussair, A. Gigandon, F. Espinasse, L. Raskine, J. Robert, A. Mangeol, C. Branger, and J. C. Petit. 2005. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J. Med. Microbiol. 54:181-185.
4. Boman, H. G. 1991. Antibacterial peptides: key components needed in immunity. Cell 65:205-207.
5. Bonnet, M., M. M. Rafi, M. L. Chikindas, and T. J. Montville. 2006. Bioen-ergetic mechanism for nisin resistance, induced by the acid tolerance response of Listeria monocytogenes. Appl. Environ. Microbiol. 72:2556-2563.
6. Calabi, E., F. Calabi, A. D. Phillips, and N. F. Fairweather. 2002. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect. Immun. 70:5770-5778.
7. Cao, M., and J. D. Helmann. 2004. The Bacillus subtilis extracytoplasmic-function sigmaX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J. Bacteriol. 186:1136-1146.
8. Dineen S. S., S. M. McBride, and A. L. Sonenshein. 2010. Integration of metabolism and virulence by Clostridium difficile CodY. J. Bacteriol. 192, 5350-5362.
9. Dineen, S. S., A. C. Villapakkam, J. T. Nordman, and A. L. Sonenshein. 2007. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 66:206-219.
10. Draper, L. A., K. Grainger, L. H. Deegan, P. D. Cotter, C. Hill, and R. P. Ross. 2009. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol. Microbiol. 71:1043-1054.
11. Fabretti, F., C. Theilacker, L. Baldassarri, Z. Kaczynski, A. Kropec, O. Holst, and J. Huebner. 2006. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 74:4164-4171.
12. Fekety, R., and A. B. Shah. 1993. Diagnosis and treatment of Clostridium difficile colitis. JAMA 269:71-75.
13. Ghantoji, S. S., K. Sail, D. R. Lairson, H. L. DuPont, and K. W. Garey. 2010. Economic healthcare costs of Clostridium difficile infection: a systematic review. J. Hosp. Infect. 74:309-318.
14. Giesemann, T., G. Guttenberg, and K. Aktories. 2008. Human alpha-de-fensins inhibit Clostridium difficile toxin B. Gastroenterology 134:2049-2058.
15. Guo, L., K. B. Lim, C. M. Poduje, M. Daniel, J. S. Gunn, M. Hackett, and S. I. Miller. 1998. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189-198.
16. Hancock, R. E., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
17. Hancock, R. E., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
18. Hancock, R. E., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U.S.A. 97:8856-8861.
19. Haraldsen, J. D., and A. L. Sonenshein. 2003. Efficient sporulation in Clos-tridium difficile requires disruption of the sigmaK gene. Mol. Microbiol. 48:811-821.
20. Heap, J. T., O. J. Pennington, S. T. Cartman, G. P. Carter, and N. P. Minton. 2007. The ClosTron: a universal gene knock-out system for the genus Clos-tridium. J. Microbiol. Methods 70:452-464.
21. Heidrich, C., U. Pag, M. Josten, J. Metzger, R. W. Jack, G. Bierbaum, G. Jung, and H. G. Sahl. 1998. Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl. Environ. Microbiol. 64:3140-3146.
22. Hennequin, C., C. Janoir, M. C. Barc, A. Collignon, and T. Karjalainen. 2003. Identification and characterization of a fibronectin-binding protein from Clostridium difficile. Microbiology 149:2779-2787.
23. Hille, M., S. Kies, F. Gotz, and A. Peschel. 2001. Dual role of GdmH in producer immunity and secretion of the staphylococcal lantibiotics gallider-min and epidermin. Appl. Environ. Microbiol. 67:1380-1383.
24. Hirokawa, T., S. Boon-Chieng, and S. Mitaku. 1998. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinfor-matics 14:378-379.
25. Hoch, J. A. 2000. Two-component and phosphorelay signal transduction. Curr. Opin. Microbiol. 3:165-170.
26. Issa, M., A. N. Ananthakrishnan, and D. G. Binion. 2008. Clostridium difficile and inflammatory bowel disease. Inflamm. Bowel Dis. 14:1432-1442.
27. Jin, T., M. Bokarewa, T. Foster, J. Mitchell, J. Higgins, and A. Tarkowski. 2004. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172:1169-1176.
28. Karberg, M., H. Guo, J. Zhong, R. Coon, J. Perutka, and A. M. Lambowitz. 2001. Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Nat. Biotechnol. 19:1162-1167.
29. Karlstrom, O., B. Fryklund, K. Tullus, and L. G. Burman. 1998. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin. Infect. Dis. 26:141-145.
30. Kirby, J. M., H. Ahern, A. K. Roberts, V. Kumar, Z. Freeman, K. R. Acharya, and C. C. Shone. 2009. Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile. J. Biol. Chem. 284:34666-34673.
31. Klein, C., and K. D. Entian. 1994. Genes involved in self-protection against the lantibiotic subtilin produced by Bacillus subtilis ATCC 6633. Appl. Environ. Microbiol. 60:2793-2801.
32. Kovács, M., A. Halfmann, I. Fedtke, M. Heintz, A. Peschel, W. Vollmer, R. Hakenbeck, and R. Bruckner. 2006. A functional dlt operon, encoding proteins required for incorporation of d-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae. J. Bacteriol. 188:5797-5805.
33. Lauth, X., C. W. McNamara, S. Myskowski, E. Igwe, B. Beall, P. Ghosh, R. L. Gallo, and V. Nizet. 2004. A new virulence role for group A streptococcal M1 protein is protection against cathelicidin antimicrobial peptides, abstr. E-84. Abstr. 104th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
34. Lawley, T. D., S. Clare, A. W. Walker, D. Goulding, R. A. Stabler, N. Croucher, P. Mastroeni, P. Scott, C. Raisen, L. Mottram, N. F. Fairweather, B. W. Wren, J. Parkhill, and G. Dougan. 2009. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 77:3661-3669.
35. Luria, S. E., and J. W. Burrous. 1957. Hybridization between Escherichia coli and Shigella. J. Bacteriol. 74:461-476.
36. Lyras, D., and J. I. Rood. 1998. Conjugative transfer of RP4-oriT shuttle vectors from Escherichia coli to Clostridium perfringens. Plasmid 39:160-164.
37. Manganelli, R., R. Provvedi, C. Berneri, M. R. Oggioni, and G. Pozzi. 1998. Insertion vectors for construction of recombinant conjugative transposons in Bacillus subtilis and Enterococcus faecalis. FEMS Microbiol. Lett. 168:259-268.
38. McDonald, L. C., G. E. Killgore, A. Thompson, R. C. Owens, Jr., S. V. Kazakova, S. P. Sambol, S. Johnson, and D. N. Gerding. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
39. McFarland L. V., M. E. Mulligan, R. Y. Kwok, and W. E. Stamm. 1989. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320, 204-210.
40. Mitaku, S., and T. Hirokawa. 1999. Physicochemical factors for discriminating between soluble and membrane proteins: hydrophobicity of helical segments and protein length. Protein Eng. 12:953-957.
41. Mitaku, S., T. Hirokawa, and T. Tsuji. 2002. Amphiphilicity index of polar amino acids as an aid in the characterization of amino acid preference at membrane-water interfaces. Bioinformatics 18:608-616.
42. Morozova, O., and M. A. Marra. 2008. Applications of next-generation sequencing technologies in functional genomics. Genomics 92:255-264.
43. Müller, C. A., I. B. Autenrieth, and A. Peschel. 2005. Innate defenses of the intestinal epithelial barrier. Cell Mol. Life Sci. 62:1297-1307
44. Nizet, V. 2006. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 8:11-26.
45. O'Connor, J. R., D. Lyras, K. A. Farrow, V. Adams, D. R. Powell, J. Hinds, J. K. Cheung, and J. I. Rood. 2006. Construction and analysis of chromosomal Clostridium difficile mutants. Mol. Microbiol. 61:1335-1351.
46. Okuda, K., Y. Aso, J. Nakayama, and K. Sonomoto. 2008. Cooperative transport between NukFEG and NukH in immunity against the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. J. Bacteriol. 190: 356-362.
47. Otto, M., A. Peschel, and F. Gotz. 1998. Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis Tu3298. FEMS Microbiol. Lett. 166:203-211.
48. Pamp, S. J., M. Gjermansen, H. K. Johansen, and T. Tolker-Nielsen. 2008. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 68:223-240.
49. Peschel, A. 2002. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10:179-186.
50. Peschel, A., R. W. Jack, M. Otto, L. V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W. F. Nieuwenhuizen, G. Jung, A. Tarkowski, K. P. van Kessel, and J. A. van Strijp. 2001. Staphylococcus aureus resistance to human de-fensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 193:1067-1076.
51. Peschel, A., and H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
52. Qiao, M., T. Immonen, O. Koponen, and P. E. Saris. 1995. The cellular location and effect on nisin immunity of the NisI protein from Lactococcus lactis N8 expressed in Escherichia coli and L. lactis. FEMS Microbiol. Lett. 131:75-80.
53. Ra, R., M. M. Beerthuyzen, W. M. de Vos, P. E. Saris, and O. P. Kuipers. 1999. Effects of gene disruptions in the nisin gene cluster of Lactococcus lactis on nisin production and producer immunity. Microbiology 145:1227-1233.
54. Redelings, M. D., F. Sorvillo, and L. Mascola. 2007. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13:1417-1419.
55. Sallum, U. W., and T. T. Chen. 2008. Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B. Antimicrob. Agents Che-mother. 52:3006-3012.
56. Saris, P. E., T. Immonen, M. Reis, and H. G. Sahl. 1996. Immunity to lantibiotics. Antonie Van Leeuwenhoek 69:151-159.
57. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108.
58. Schwan, C., B. Stecher, T. Tzivelekidis, M. van Ham, M. Rohde, W. D. Hardt, J. Wehland, and K. Aktories. 2009. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 5:e1000626.
59. Sebaihia, M., B. W. Wren, P. Mullany, N. F. Fairweather, N. Minton, R. Stabler, N. R. Thomson, A. P. Roberts, A. M. Cerdeno-Tarraga, H. Wang, M. T. Holden, A. Wright, C. Churcher, M. A. Quail, S. Baker, N. Bason, K. Brooks, T. Chillingworth, A. Cronin, P. Davis, L. Dowd, A. Fraser, T. Felt-well, Z. Hance, S. Holroyd, K. Jagels, S. Moule, K. Mungall, C. Price, E. Rabbinowitsch, S. Sharp, M. Simmonds, K. Stevens, L. Unwin, S. Whithead, B. Dupuy, G. Dougan, B. Barrell, and J. Parkhill. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786.
60. Shafer, W. M., X. Qu, A. J. Waring, and R. I. Lehrer. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U.S.A. 95:1829-1833.
61. Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, W. Shafer, F. McAleese, T. Foster, J. Travis, and J. Potempa. 2004. Degradation of human antimicrobial pep-tide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679.
62. Smith, C. J., S. M. Markowitz, and F. L. Macrina. 1981. Transferable tetracycline resistance in Clostridium difficile. Antimicrob. Agents Che-mother. 19:997-1003.
63. Stein, T., S. Borchert, P. Kiesau, S. Heinzmann, S. Kloss, C. Klein, M. Helfrich, and K. D. Entian. 2002. Dual control of subtilin biosynthesis and immunity in Bacillus subtilis. Mol. Microbiol. 44:403-416.
64. Stein, T., S. Heinzmann, S. Dusterhus, S. Borchert, and K. D. Entian. 2005. Expression and functional analysis of the subtilin immunity genes spaIFEG in the subtilin-sensitive host Bacillus subtilis MO1099. J. Bacteriol. 187:822-828.
65. Tasteyre, A., M. C. Barc, A. Collignon, H. Boureau, and T. Karjalainen. 2001. Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect. Immun. 69:7937-7940.
66. Thomas, C. M., and C. A. Smith. 1987. Incompatibility group P plasmids: genetics, evolution, and use in genetic manipulation. Annu. Rev. Microbiol. 41:77-101.
67. Viscidi, R., S. Willey, and J. G. Bartlett. 1981. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81:5-9.
68. Vonberg, R. P., E. J. Kuijper, M. H. Wilcox, F. Barbut, P. Tull, P. Gastmeier, P. J. van den Broek, A. Colville, B. Coignard, T. Daha, S. Debast, B. I. Duerden, S. van den Hof, T. van der Kooi, H. J. Maarleveld, E. Nagy, D. W. Notermans, J. O'Driscoll, B. Patel, S. Stone, and C. Wiuff. 2008. Infection control measures to limit the spread of Clostridium difficile. Clin. Microbiol. Infect. 14(Suppl. 5):2-20.
69. Waligora, A. J., C. Hennequin, P. Mullany, P. Bourlioux, A. Collignon, and T. Karjalainen. 2001. Characterization of a cell surface protein of Clostrid-ium difficile with adhesive properties. Infect. Immun. 69:2144-2153.
70. Warny, M., J. Pepin, A. Fang, G. Killgore, A. Thompson, J. Brazier, E. Frost, and L. C. McDonald. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084.
71. Willey, J. M., and W. A. van der Donk. 2007. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61:477-501.
72. Wüst, J., and U. Hardegger. 1983. Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile. Antimicrob. Agents Chemother. 23:784-786.
73. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.